Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 31Thoracic 3Genitourinary 2Gastrointestinal 2Dermatologic 2Breast 2Sarcoma 1NET 1Head & Neck 1Endocrine 1CNS 1

Conditions

Melanoma 12Lymphoma, T-Cell, Cutaneous 10Mycosis Fungoides 8Lymphoma, Non-Hodgkin 8Lymphoma, Large B-Cell, Diffuse 8Hodgkin Disease 8Carcinoma, Non-Small-Cell Lung 8Sezary Syndrome 7Lymphoma, Follicular 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Pancreatic Neoplasms 6Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, B-Cell, Marginal Zone 6Lymphoma 6Colorectal Neoplasms 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Mantle-Cell 5Leukemia, Lymphocytic, Chronic, B-Cell 5Burkitt Lymphoma 5Squamous Cell Carcinoma of Head and Neck 4Prostatic Neoplasms 4Ovarian Neoplasms 4Lymphoma, Large-Cell, Anaplastic 4Breast Neoplasms 4Waldenstrom Macroglobulinemia 3Urinary Bladder Neoplasms 3Stomach Neoplasms 3Lung Neoplasms 3Immunoblastic Lymphadenopathy 3Esophageal Neoplasms 3

Interventions

pembrolizumab 7Cyclophosphamide 6Paclitaxel 4Flow Cytometry 4Therapeutics 3Psychiatric Rehabilitation 3Polymerase Chain Reaction 3Cisplatin 3sargramostim 2liposomal amphotericin B 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Ondansetron 2Methylprednisolone 2Itraconazole 2Immunoenzyme Techniques 2Gemcitabine 2Filgrastim 2Etoposide 2Dexamethasone 2Caspofungin 2Carboplatin 2Calcium Dobesilate 2Bortezomib 2Aprepitant 2Analgesia 2Amplified Fragment Length Polymorphism Analysis 2tislelizumab 1temsirolimus 1tanespimycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Ovarian Epithelial × Gemcitabine × Dermatologic × Clear all
NCT03872947 2025-08-03

A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors

Toray Industries, Inc

Phase 1 Active not recruiting
138 enrolled
DermatologicGastrointestinalGenitourinaryGynecologic

Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Fallopian Tube Neoplasms, Melanoma, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT00014456 2013-08-28

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Dartmouth-Hitchcock Medical Center

Phase 1 Completed
35 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

AIDS-related Kaposi sarcoma, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Esophageal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Unknown Primary, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Sarcoma, Kaposi, Osteosarcoma, Stomach Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡